Mainstream

Tela bio sees 23 27% revenue growth for 2025 with expanded sales strategy

TELA Bio sees 23-27% revenue growth for 2025 with expanded sales strategy

TELA Bio sees 23-27% revenue growth for 2025 with expanded sales strategy

Post ContenttelaRead More

You might also be interested in reading Circle shifts legal home to US ahead of IPO.

March 21, 2025
In Mainstream